News

Staff Scientist Kathryn Hastie of The Scripps Research Institute (TSRI) has won the 2017 William E. and Diane M. Spicer Young Investigator Award.

Annual Nature Index supplement ranks research institutes on influence over scientific patents.

Scientists at The Scripps Research Institute have developed a highly efficient new method for making ribonucleic acid (RNA) molecules in the laboratory.

Scripps Research study of interferon gamma reveals new principle of cell signaling.

These new findings provide the first molecular understanding of the pathology of the disease known as Diamond-Blackfan anemia.

Scientists at Scripps Research have invented a versatile method for identifying proteins that can feasibly be targeted with drugs to treat disease.

Future studies will attempt to explain the biological significance of these two distinct cell types competing for a shared source of survival stimuli.

In their study, the researchers injected HIV immunogens into the flanks of four calves and waited for their immune systems to respond.

Atomic-scale snapshot reveals new regions on HIV’s envelope trimer protein that could be targets for small molecule inhibitor development.

A team of scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded nearly $2 million from the National Institute of Mental Health of the National Institutes of Health.

Mice in new Scripps Research study sprinted faster but had less endurance over longer distances.

Scientists have a long way to go to fully understand how our brains forget unused and unimportant memories and make space for new ones.

Optimized immunizations reliably elicit protective antibodies in preclinical study, marking an important milestone on the way to an effective HIV vaccine.

Scripps Research scientists have improved a state-of-the-art gene-editing technology to advance the system’s ability to target, cut and paste genes within human and animal cells.

"The new grant supports the idea that RNA is a legitimate target to treat disease."

New research could improve the effectiveness of flu vaccines and therapies

Scientists at Scripps Research have solved a cellular mystery that may have important implications for fundamental biology and diseases like ALS.

World-class research institute and new innovation center partner to accelerate early translational research.

The next step in this research will be to license the vaccine to an outside company for partnering in clinical trials.

Matthew Disney is a finalist for the prestigious Blavatnik National Awards for Young Scientists.

"This was a tenacious effort—over a decade—to conquer a global threat."

"Joel’s professional experience and business leadership add to the expertise of our current board members."

Assistant Professor Seth Tomchik of the Florida campus of The Scripps Research Institute (TSRI) has received $2 million in funding from the National Institutes of Health’s National Institute of Neurological Disorders and Stroke (NINDS).

Like a flu vaccine, an effective HIV vaccine needs to protect against multiple strains.